Research
GeneDx (WGS) Stock Analysis & Research
- Latest rating
- Sell
- Latest report
- Aug 9, 2026
- Reports
- 1
- Sector
- Healthcare
GeneDx Holdings (WGS) develops and sells clinical genetic tests, earning revenue mainly from diagnostic test reports for exome and genome sequencing. It pioneered exome sequencing in 2012 and acquired Fabric Genomics in May 2025 to support international expansion and AI-based interpretation.



